KME

USPTO USPTO 2003 ABANDONED - NO STATEMENT OF USE FILED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke KME wurde als Wortmarke am 30.05.2003 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".

Markendetails

Markenform Wortmarke
Aktenzeichen 78256313
Anmeldedatum 30. Mai 2003
Veröffentlichungsdatum 14. Dezember 2004

Markeninhaber

Heron Cove
Barrymore, Athlone
IE

Markenvertreter

Waren und Dienstleistungen

5 PHARMACEUTICAL AND VETERINARY PREPARATIONS IN WHICH THE PHARMACEUTICALLY OR VETERINARILY ACTIVE AGENT IS A KNOWN CHEMICAL ENTITY, NAMELY, NATURAL, SEMI-SYNTHETIC AND SYNTHETIC STEROIDS AND THEIR DERIVATIVES, NON-STEROIDAL ESTROGENS AND MIXTURES THEREOF; A- AND B- ADRENERGIC AGONISTS AND BLOCKERS; ALCOHOL DETERRANTS; ALDOSE REDUCTASE INHIBITORS; NARCOTIC AND NON-NARCOTIC; ANALGESIC ANESTHETICS; ANOREXICS; ANTI-ACNE AGENTS; ANTI ALLERGICS; ANTIANDROGENS AND ANTIESTROGENS; ANTIANGINALS; ANTIARRHYTHMICS; ANTIARTERIOSCLEROTICS; ANTIARTHRITIC/ANTIRHEUMATTCS; ANTIBACTERIAL AGENTS; ANTICONVULSANTS; ANTIDEPRESSANTS; ANTIDIABETICS; ANTIDIARRHEAL AGENTS; ANTIDIURETICS; ANTIFUNGAL AGENTS; ANTIGLAUCOMA AGENTS; ANTIGONADOTROPINS; ANTIHISTAMINES ANTIHYPERLIPOPROTEINEMICS; ANTIHYPERTENSIVE AGENTS; ANTIHYPOTENSIVE AGENTS; NON-STEROIDAL ANTI-INFLAMMATORY AGENTS; ANTIMIGRAINE AGENTS; ANTINAUSEANT AGENTS; ANTINEOPLATICS AGENTS AND ADJUNCTS; ANTIPARKINSONIAN AGENTS; ANTIHYPERPROSTATIC AGENTS; ANTIPURITICS; ANTIPSORIATIC AGENTS; ANTIPSYCHOTIC AGENTS; ANTIPYRETICS; ANTISPASMODIC AGENTS; ANTITHROMBOTIC AGENTS; ANTITUSSIVE AGENTS; ANTIULCERATIVE AGENTS; ANTIUROLITHIC AGENTS; ANTIVRAL AGENTS; ANXIOLYTIC AGENTS; BENZODIAZEPINE ANTAGONISTS; BRONCHODILATORS; CALCIUM CHANNEL BLOCKERS; CARDTOTONICS; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS AND REACTIVATORS; CENTRAL NERVOUS SYSTEM STIMULANTS AND AGENTS; DECONGESTANTS; DIURETICS; DOPAMINE RECEPTOR AGONISTS; HEPATIC ENZYME INDUCERS; GASTRIC SECRETION INHIBITORS; GLUCOCORTICOIDS; GONAD-STIMULATING AGENTS AND GONADOTROPIC HORMONES; HEPARIN ANTAGONISTS; HEPATOPROTECTANTS; IMMUNOMODULATORS AND IMMUNOSUPPRESSANTS LH-RH AGONISTS; LIPOTROPIC AGENTS; MINERALOCORTICOIDS; MONOAMINE OXIDASE INHIBITORS; MUCOLYTIC AGENTS; MUSCLE RELAXANTS; NARCOTIC ANTAGONISTS; NEUROPROTECTiVE AGENTS; NOOTROPICAL AGENTS; OPHTHALMIC AGENTS; PERISTALTIC STIMULANTS; PROLACTIN INHIBITORS; PROSTAGLANDINS AND THEIR ANALOGS; PROTEASE INHIBITORS; RESPIRATORY STIMULANTS; SCLEROSING AGENTS; SEDATIVES AND HYPNOTICS; THROMBOLYTIC AGENTS; URICOSURICS; CEREBRAL, CORONARY AND PERIPHERAL VASODILATORS; VASOPROTECTANTS; ANTICOAGULANTS; HEMATINICS; AGENTS FOR BENIGN PROSTATE HYPERTROPHY, MULTIPLE SCLEROSIS AND URINARY INCONTINENCE
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1378256313